Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.
Your report is on its way

Thank you. Your copy of Top 10 Small Caps to Buy in May is on its way.

Stockbroking Service Photo
Live opportunities

The companies we back.

Disclosure

Clear Capital Markets is engaged to market the companies featured below. This is a financial promotion.

Featured Placing
AI · Identity · Pre-IPO · AIM (LSE)

Humanity One

A pre-IPO group building proprietary applications inside the World ecosystemco-founded by Sam Altman.

It offers UK investors a regulated entrypoint ahead of admission to AIM, in a category where retail access at this stage is rare.

Pre-IPO · qualifying investors only
Read the Humanity One briefing
AI · Medical · LSE

MedPal AI

(MPAL)

A UK-listed medical AI company developing clinical decision-support tools for healthcare providers.

A recently announced supply agreement with Eli Lilly puts the business inside oneof the largest pharmaceutical supply chains in the world.

Read the MedPal AI briefing
Digital Assets · Aquis Exchange

Roundhouse Digital

A pre-IPO group building proprietary applications inside the World ecosystem co-founded by Sam Altman.

It offers UK investors a regulated entrypoint ahead of admission to AIM, in acategory where retail access at thisstage is rare.

Read the Roundhouse briefing
Risk warning · pre-IPO opportunities

The following warning applies to the pre-IPO opportunities above (Humanity One):

Don't invest unless you're prepared to lose all the money you invest. These are high-risk investments. They can behard to sell, their value can go down as well as up, and you are unlikely to be protected if something goes wrong. Take 2 minutes to learn more.

The companies named above are mentioned for informational purposes. This is not a recommendation to buy, sell or hold. The market value of these instruments can fall as well as rise. Past performance is not a guide to future performance.